Browsing by Author Alavi, Maryam

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2013Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS StudyDay, Carolyn; Haber, Paul; Alavi, Maryam; Balcomb, Annie C.; Bath, Nicky; Dore, Gregory J.; Dunlop, Adrian J; Grebely, Jason; Micallef, Michelle; Treloar, Carla; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineAssessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study, Clinical Infectious Diseases, vol.57, Suppl 2, 2013,pp S62-S69
2012Effect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infectionDay, Carolyn; Haber, Paul; Alavi, Maryam; Dore, Gregory; Grebely, Jason; Hellard, Margaret; Kaldor, John; Lloyd, Andrew; Matthews, Gail V; Petoumenos, Kathy; van Beek, I; Yeung, Barbara; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineEffect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infection, Journal of Gastroenterology and Hepatology, vol.27, 5, 2012,pp 957-965
2015The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS studyDay, Carolyn; Haber, Paul; Alavi, Maryam; Balcomb, Annie C.; Bath, Nicky; Bruneau, Julie; Dore, Gregory; Dunlop, Adrian; Fortier, Emmanuel; Grebely, Jason; Micallef, Michelle; Treloar, Carla; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineThe effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study, International Journal of Drug Policy, vol.26, 11, 2015,pp 1094-1102
2015Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS studyDay, Carolyn; Haber, Paul; Alavi, Maryam; Balcomb, Annie C.; Bath, Nicky; Dore, Gregory J.; Dunlop, Adrian; Fortier, Emmanuel; Grebely, Jason; Micallef, Michelle; Treloar, Carla; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineEffect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS study, Journal of Viral Hepatitis, vol.22, 11, 2015,pp 914-925
2015Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis CDay, Carolyn; Haber, Paul; Alavi, Maryam; Bruneau, Julie; Dolan, Kate; et al, Various; Kaldor, John M; Matthews, Gail; Petoumenos, Kathy; Spelman, Tim; Van Beek, Ingrid; Walsh, Nick; Yeung, Barbara; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineInjecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C, International Journal of Drug Policy, vol.26, 10, 2015,pp 976-983
2017Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014)George, Jacob; Alavi, Maryam; Amin, Janaki; Dore, Gregory; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Matthews, Gail V; Waziry, Reem; Westmead Clinical School: Westmead Institute for Medical ResSurvival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014), Hepatology Communications, vol.1, 8, 2017,pp 736-747
2016Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: a population-based study, 1995-2012George, Jacob; Alavi, Maryam; Amin, Janaki; Dore, Gregory; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Western Clinical School: Westmead Institute for Medical ResTime to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: a population-based study, 1995-2012, Journal of Hepatology, vol.65, 5, 2016,pp 879-887
2016Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: The ETHOS StudyDay, Carolyn; Haber, Paul; Weltman, Martin; Alavi, Maryam; Balcomb, Annie C.; Bath, Nicky; Dore, Gregory; Dunlop, Adrian; Grebely, Jason; Micallef, Michelle; Phung, Nghi; Treloar, Carla; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction Medicine; Nepean Clinical School: MedicineTreatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: The ETHOS Study, Addiction, vol.111, 2, 2016,pp 311-319
2016Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014)George, Jacob; Alavi, Maryam; Amin, Janaki; Dore, Gregory J.; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Matthews, Gail; Waziry, Reem; Western Clinical School: Westmead Institute for Medical ResTrends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014), Journal of Hepatology, vol.65, 6, 2016,pp 1086-1093